FSHR and neoplasm: First, extragonadal expression of FSHR can be controversial, as some authors have suggested that the reliable assessment of tumor samples and control samples requires the use of monoclonal antibodies (which act selectively on a specific isoform of FSHR) instead of the polyclonal antibodies used in our study.